HIV/AIDS Vaccines

Some propelled stage clinical trials of HIV immunization are continuous. Even though the production of a compelling HIV-1 antibody remains a tremendous test, the proceeding with advance in these zones gives motivation to be idealistic about our definitive capacity to control the spread of AIDS. Development of a HIV/AIDS immunization has been easing back on the grounds that established ways to deal with antibody improvement have not yielded an antibody.

 

  • Age acceleration effects due to HIV infection
  • Attenuated Virus Vaccines in HIV Infection
  • HIV stems vaccination
  • HIV Vaccine development from Animal Models
  • Microbicides for sexually Transmitted Diseases
  • Recombinant vector vaccine

Related Conference of HIV/AIDS Vaccines

April 18-19, 2022

Global Summit on Vaccines and Immunology

Madrid, Spain
June 23-24, 2022

35th World Congress on Vaccines and Immunization

Bangkok, Thailand
September 05-06, 2022

42nd Global Summit and Expo on Vaccines & Immunology

Paris, France
September 15-16, 2022

International Conference on Vaccine and Vaccine research

Paris, France
October 07-08, 2022

34th International Conference on Vaccines and Immunization

Zurich, Switzerland

HIV/AIDS Vaccines Conference Speakers

Recommended Sessions

Related Journals

Are you interested in